How One Tiny Drug Developer Could Take Down Pfizer and Co.
Feb 20th, 2009 | By Jim Nelson | Category: Featured, Investing Strategies
Pharmaceutical behemoth Pfizer currently sports a market cap of $102 billion and annual revenue of $48 billion. Merck, another mammoth drug maker, has a $65 billion market cap and annual revenue of $24 billion. GlaxoSmithKline, with a market cap of $95 billion, generated $22.7 billion in revenue over the past ...read more
